{"nct_id":"NCT03118843","title":"Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2017-04-25","start_date_type":"ACTUAL","primary_completion_date":"2018-03-19","primary_completion_date_type":"ACTUAL","completion_date":"2018-03-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}